Rosa M. Alves
Assistant Dean for Global Compliance & Programming, Seton Hall Law School
healthlaw@shu.edu | 973-642-8382 or 973-761-9000 ext. 8382
PROGRAM SCHEDULED for June 2-5, 2025 | In-Person
PROGRAM SCHEDULED for October 6-9, 2025 | In-Person/Hybrid
Agenda Below - All Times in Eastern Standard Time
8:45 - 9:00am
9:00 - 9:20am
Rosa M. Alves
Assistant Dean for Global Compliance & Programming, Seton Hall Law School
Jacob T. Elberg
Professor of Law and Faculty Director, Center for Health & Pharmaceutical Law, Seton Hall Law School
9:20 - 10:00
Rosa M. Alves
Assistant Dean for Global Compliance & Programming, Seton Hall Law School
Jacob T. Elberg
Professor of Law and Faculty Director, Center for Health & Pharmaceutical Law, Seton Hall Law School
10:05 - 10:55
Jacob T. Elberg
Professor of Law and Faculty Director, Center for Health & Pharmaceutical Law, Seton Hall Law School
10:55 - 11:10
11:10 - 12:30
Keren F. Bisnauth
Associate Vice President, Legal & Regulatory, Porzio Life Sciences, LLC (an RLDatix Company)
12:30 - 1:30
1:30 - 2:40
2:45 - 3:50
3:50 - 4:05
4:05 - 5:15
4:05 - 5:15
8:45 - 9:00
9:00 - 10:15
Pamela Coyle Brecht
Partner, Pietragallo Gordon Alfano Bosick & Raspanti, LLP
10:15 - 10:30
10:30 - 11:45
11:45 - 12:45
12:45 - 2:05
Stephen Chien
Vice President, Global Compliance Lead, Gilead Sciences, Inc.
2:10 - 3:00
Moderator: Jacob T. Elberg
Professor of Law and Faculty Director, Center for Health & Pharmaceutical Law, Seton Hall Law School
3:00 - 3:15
3:15 - 4:40
Gillian M. Russell
Counsel, FDA & Life Sciences, King & Spalding LLP
4:45 - 5:30
Craig Carpenito
Partner, Special Matters & Government Investigations, King & Spalding LLP
Adam Baker
Partner, Special Matters & Government Investigations, King & Spalding LLP
5:30 - 6:30
8:45 - 9:00
9:00 - 10:00
10:00 - 10:15
10:15 - 11:20
11:20 - 12:45
12:45 - 1:45
1:45 - 3:00
Joseph Zimmerman
Senior Vice President, Chief Compliance Officer, SpringWorks Therapeutics, Inc.
Jennifer McGee
Senior Vice President & Global Chief Compliance Officer, Otsuka Pharmaceuticals, Inc.
Jill Fallows Macaluso
Corp. VP & North America Chief Ethics & Compliance Officer, Novo Nordisk
Margaret Sparks
Head of Compliance, Vaccines (U.S.), North America Ethics and Business Integrity, Sanofi
Moderator: Jacob T. Elberg
Professor of Law and Faculty Director, Center for Health & Pharmaceutical Law, Seton Hall Law School
3:00 - 3:15
3:15 - 4:45
Joseph Zimmerman
Senior Vice President, Chief Compliance Officer, SpringWorks Therapeutics, Inc.
Christie Camelio
Senior Vice President, Chief Compliance Officer, Insmed
Jennifer McGee
Senior Vice President & Global Chief Compliance Officer, Otsuka Pharmaceuticals, Inc.
Jill Fallows Macaluso
Corp. VP & North America Chief Ethics & Compliance Officer, Novo Nordisk
Margaret Sparks
Head of Compliance, Vaccines (U.S.), North America Ethics and Business Integrity, Sanofi
8:45 - 9:00
9:00 - 10:15
Jeremy Berkowitz
Senior Privacy Director & Deputy Chief Privacy Officer, Paul Hastings, LLP
10:15 - 10:30
10:30 - 11:30
Anna Loveless
Associate Director, Advanced Solutions within the Global Development Organization, Johnson & Johnson Innovative Medicine
Michael Driscoll
Managing Member, Driscoll & DeSimone, LLC & Former, Director, Global Strategic Insights, Health Care Compliance, Johnson & Johnson
Jacob T. Elberg
Professor of Law and Faculty Director, Center for Health & Pharmaceutical Law, Seton Hall Law School
11:35 - 12:30
James Sheehan
Chief, Charities Bureau, New York Attorney General’s Office
12:30 - 1:30
1:30 - 2:35
Vikas Khanna
First Assistant U.S. Attorney, U.S. Attorney’s Office, District of New Jersey
John Kelly
Partner & Chair of the Healthcare Department and Industry Practice, Barnes & Thornburg LLP
James Sheehan
Chief, Charities Bureau, New York Attorney General’s Office
Katie Holden
Federal Bureau of Investigations, Newark Field Office
Moderator: Jacob T. Elberg
Professor of Law and Faculty Director, Center for Health & Pharmaceutical Law, Seton Hall Law School
2:45 - 3:40
Vikas Khanna
First Assistant U.S. Attorney, U.S. Attorney’s Office, District of New Jersey
3:45
